Showing results (2311-2320 of 2,609) with videos related to
Sort By:
Pageof 261
Oncology Research|January 8, 2024
Recent updates on nano-phyto-formulations based therapeutic intervention for cancer treatmentAbhishek Wahi, Mamta Bishnoi, Neha Raina, et al.Oncology Research|January 8, 2024
Aldo-keto reductase family member C3 (AKR1C3) promotes hepatocellular carcinoma cell growth by producing prostaglandin F2αKuo-Shyang Jeng, Po-Yu Cheng, Yueh-Hsien Lin, et al.Oncology Research|January 8, 2024
Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cellsRoghayeh Ghorbani, Mahmoud Gharbavi, Ali Sharafi, et al.Oncology Research|January 8, 2024
Leveraging diverse cell-death patterns to predict the clinical outcome of immune checkpoint therapy in lung adenocarcinoma: Based on muti-omics analysis and vitro assayHongyuan Liang, Yanqiu Li, Yonggang Qu, et al.Oncology Research|April 1, 2024
IQGAP3 promotes the progression of glioma as an immune and prognostic markerXiaofeng Gao, Juanjuan Ge, Xuzheng Gao, et al.Oncology Research|April 1, 2024
Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinomaJun Liu, Wenli Li, Ruyue Lu, et al.Oncology Research|April 1, 2024
Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC)Kunlun Li, Dandan Li, Barbod Hafez, et al.Oncology Research|April 1, 2024
DPY19L3 promotes vasculogenic mimicry by its C-mannosyltransferase activityHassan Baydoun, Yuji Kato, Hiroki Kamo, et al.Oncology Research|July 26, 2024
Fibroblast activation protein (FAP) as a prognostic biomarker in multiple tumors and its therapeutic potential in head and neck squamous cell carcinomaRuifang Li, Xinrong Nan, Ming Li, et al.Pageof 261